medigraphic.com
ISSN 1995-9494 (Electronic)
Revista del Hospital Clínico Quirúrgico "Arnaldo Milián Castro"

2012, Number 4

<< Back Next >>

Acta Med Cent 2012; 6 (4)

Educational intervention to improve outcomes of patients with diabetes debut and a history of hypertension

Méndez GL, Fleites AA, Batista BMÁ, Fernández EH, Artiles DL, Monteagudo MCI

Language: Spanish
References: 11
Page:
PDF size: 72.62 Kb.


ABSTRACT

The main cause of death of the person with type 2 diabetes mellitus is cardiovascular. Its prevention involves an integrated management of all risk factors. Objective: To evaluate the results of an intervention to improve the outcome of patients with type 2 diabetes debut and a history of hypertension that were treated with betablockers at the Chiqui Lubián Gomez University Polyclinic. Material and Method: prospective quasi-experimental study in an intentional sample of 22 patients with type 2 diabetes mellitus debut and a history of hypertension who attended the multidisciplinary consultation of diabetes mellitus in the period from January to December 2011. Results: there was a prevalence of female patients -16 patients (72.7%) - and the age group between 50 and 69 years - (77.2%). The hypertension control was achieved with a change to inhibitors of angiotensin converting enzyme (90.9%). Metabolic control, by quarter, improved significantly until reaching a 95.4% in the last one. Favorable changes in lifestyle, such as incorporating the practice of physical exercises (81.8%), were achieved. They ensure a better quality of life. With regard to body weight, at the start of the intervention there were 12 (54.5%) overweight patients and at the end they were reduced to seven (31.8%). It was possible that 100% of patients had a proper diet to control the disease, but only one patient (18.1%) stopped smoking, which is not significant. Better results could be achieved in the long term. Generally, the intervention was successful in 90.9% of patients. Conclusions: Patients presenting with type 2 diabetes mellitus and a history of hypertension evolve favorably with a treatment of angiotensin converting enzyme inhibitors as hypotensive and good metabolic control with lifestyle changes.


REFERENCES

  1. Prevención de Diabetes Mellitus [Internet]. Cuba: III Encuesta Nacional de factores de riesgo y enfermedades no transmisibles; 2001-2010. [citado 9 Feb 2011]. Disponible en: www.minsal.gob.cl/portal/url/.../c4034eddbc96ca6de0400101640159b8.pdf

  2. Pérez Caballero MD, Dueñas Herrera A, Alfonso Guerra JP, Vásquez Vigoa A, Navarro Despaigne D, Hernández Cueto M, et al. Hipertensión arterial. Guía para la prevención, diagnóstico y tratamiento. Comisión Nacional Técnica Asesora del Programa de hipertensión arterial. La Habana: Ciencias Médicas; 2008.

  3. Diabetes mellitos. En: Cuba, Ministerio de Salud Pública. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2009. Ciudad de la Habana: MINSAP; 2009.

  4. Rodríguez Carranza SI, Aguilar-Salinas CA. Tratamiento de la hipertensión arterial en el paciente con diabetes mellitus tipo 2. Rev Endocrinol Nutr. 2006;14(2):59-72.

  5. Gress TW, Nieto FJ, .Shahar E, .Woffard MR. Hypertension and antihypertensive therapy as risk factors for type 2 Diabetes mellitus. 2010. N Engl J Med. 2010 Mar 30;342(13):905-12.

  6. Mbanya JC. Conseguir que cambien las cosas en el mundo. Diabetes Voice [Internet]. 2011 [citado 9 Feb 2012];54(3):[aprox. 2 p.]. Disponible en: http://www.diabetesvoice.org/files/attachments/2011_3_JCMed_ES.pdf

  7. Morales Salinas A. Los betabloqueadores como primera opción del tratamiento en la hipertensión no complicada: ¿posible o no? Rev Finlay [Internet]. 2011 [citado 7 Jul 2012];1(1): [Aprox. 7 p]. Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/27/54

  8. Morales Salinas A. Dogmas y actualidades del uso de los beta-bloqueadores en prevención secundaria. Primera parte. Rev Finlay [Internet]. 2011[citado 10 Dic 2011];1(2):[aprox. 6 p.]. Disponible en: www.revfinlay.sld.cu/index.php/finlay/article/view/47

  9. Diabetes mellitos. En: Álvarez Sintes R. Temas de Medicina General Integral. Vol II. 2da ed. La Habana: Ciencias Médicas; 2008. p. 852-62.

  10. Melchor I, García-Senchermes C, Martínez P, Valero S, Salinas S, Quesada JA, et al. ¿Distorsión en la mortalidad por diabetes e hipertensión en la Comunidad Valenciana? Gac Sanit. 2011;25(esp Congreso 2):219.

  11. Socarrás M, Blanco AJ, Vázquez VA, González HD, Licea PM. Factores de riesgo de enfermedad aterosclerótica en la diabetes mellitus tipo 2. Rev Cubana Med [Internet]. 2003 Jun [citado 12 May 2007];42(2):108-12. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75232003000200003&lng=es




2020     |     www.medigraphic.com